Industries > Pharma > Pharmaceutical Logistics Market Report 2024-2034

Pharmaceutical Logistics Market Report 2024-2034

Forecasts by Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), by Logistic Components (Storage, Transportation, Monitoring Components), by Product (Generic Drugs and Branded Drugs), by End-users (Pharmaceutical manufacturers, Pharmaceutical Distributors and Wholesalers, Others), by Application (Bio Pharma, Chemical Pharma, Specialised Pharma) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 19 January 2024
PAGES: 294
PRODUCT CODE: PHA1311
SUBMARKET: Contract Services

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1311 Categories: , Tags: , , , , ,

The Pharmaceutical Logistics Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Rising Globalization and Focus on Cost-efficiency and Sustainability Driving Industry Growth
Rising globalization in the pharmaceutical industry compels companies to expand operations globally, leading to increased demand for efficient and reliable logistics services. Simultaneously, there’s a growing emphasis on cost-efficiency, prompting pharmaceutical firms to seek optimized supply chain solutions to reduce expenses while maintaining high-quality standards.

Moreover, the focus on sustainability plays a pivotal role in shaping the pharmaceutical logistics market. Companies are embracing eco-friendly practices and adopting greener logistics solutions to minimize their environmental footprint, thus aligning with evolving regulations and meeting consumer expectations for responsible business practices.

This convergence of factors—globalization, cost-efficiency endeavours, and sustainability commitments—acts as a driving force, propelling innovation and transformation within the pharmaceutical logistics sector, fostering its growth and evolution.

Cold chain management presents a significant challenge for the pharmaceutical logistics market due to the intricate requirements of transporting temperature-sensitive products. Maintaining the integrity of these biopharmaceuticals, vaccines, and other temperature-sensitive drugs throughout the supply chain is crucial. Variations in temperature during transportation or storage can compromise their efficacy, rendering them ineffective and unsafe for use.

The complexities of cold chain management include ensuring consistent temperature control, monitoring environmental conditions, and adhering to strict regulations across various geographic locations. Additionally, managing the cold chain involves substantial investment in specialized infrastructure, such as refrigerated storage facilities and temperature-controlled transportation vehicles, adding to operational costs.

Logistics providers face the challenge of implementing robust technologies and processes to guarantee precise temperature monitoring, traceability, and contingency planning in case of unforeseen disruptions. Variations in climates and infrastructural differences across regions further intensify these challenges, demanding adaptable and scalable solutions for effective cold chain logistics, making it a significant hurdle within the pharmaceutical logistics industry.

What Questions Should You Ask before Buying a Market Research Report?
• How is the pharmaceutical logistics market evolving?
• What is driving and restraining the pharmaceutical logistics market?
• How will each pharmaceutical logistics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
• How will the market shares for each pharmaceutical logistics submarket develop from 2024 to 2034?
• What will be the main driver for the overall market from 2024 to 2034?
• Will leading pharmaceutical logistics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2024 and 2034? What are the implications of pharmaceutical logistics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the pharmaceutical logistics market?
• Where is the pharmaceutical logistics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the pharmaceutical logistics market today, and over the next 10 years:
• Our 294-page report provides 144 tables, 218 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the pharmaceutical logistics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising pharmaceutical logistics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Mode of Operation
• Cold Chain Transport
• Non-Cold Chain Transport

Logistic Components
• Storage
• Transportation
• Monitoring Components

Product
• Generic Drugs
• Branded Drugs

End-users
• Pharmaceutical Manufacturers
• Pharmaceutical Distributors and Wholesalers
• Others

Application
• Bio Pharma
• Chemical Pharma
• Specialized Pharma

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• Spain
• UK
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Argentina
• Rest of Latin America

MEA
• GCC Countries
• South Africa
• Rest of MEA

Pharmaceutical Logistics Market Report 2024-2034
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Pharmaceutical logistics Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report
• Agility
• Americold Logistics, Inc.
• AWL India Private Limited
• C.H. Robinson Worldwide, Inc.
• CMA CGM Group
• Deutsche Post AG
• DSV
• FedEx
• KERRY LOGISTICS NETWORK LIMITED
• Kuehne+Nagel
• Lineage, Inc.
• Maersk
• Movianto
• United Parcel Service of America, Inc.
• V-Xpress

Overall world revenue for pharmaceutical logistics market, 2024 to 2034 in terms of value the market will surpass US$93 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the pharmaceutical logistics market, 2024 to 2034 report help you?
In summary, our 290+ page report provides you with the following knowledge:

• Revenue forecasts to 2034 for Pharmaceutical logistics market, 2024 to 2034 Market, with forecasts for mode of operation, logistic components, product, end-users and application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2034 for five regional and 20 key national markets – See forecasts for the Pharmaceutical logistics Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the pharmaceutical logistics market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the pharmaceutical logistics market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharmaceutical Logistics Market Report 2024-2034: Forecasts by Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), by Logistic Components (Storage, Transportation, Monitoring Components), by Product (Generic Drugs and Branded Drugs), by End-users (Pharmaceutical manufacturers, Pharmaceutical Distributors and Wholesalers, Others), by Application (Bio Pharma, Chemical Pharma, Specialised Pharma) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharmaceutical Logistics Market Report 2024-2034

    Download sample pages

    Complete the form below to download your free sample pages for Pharmaceutical Logistics Market Report 2024-2034

      Latest Pharma news

      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ

      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ

      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ

      Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

      The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

      12 April 2024

      READ